Jeff Boyd

发表

Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer

Francis S. Collins, Fergus J. Couch, Barbara L. Weber, 1994, Nature Genetics.

Stratification of Intermediate-Risk Endometrial Cancer Patients into Groups at High Risk or Low Risk for Recurrence Based on Tumor Gene Expression Profiles

Adam B. Olshen, A. Olshen, A. Viale, 2005, Clinical Cancer Research.

Genetic Analysis of the Early Natural History of Epithelial Ovarian Carcinoma

Adam B. Olshen, Mark E. Robson, Kenneth Offit, 2010, PloS one.

Microarray Analysis of Early Stage Serous Ovarian Cancers Shows Profiles Predictive of Favorable Outcome

Jingqin Luo, Douglas A Levine, Edwin S Iversen, 2009, Clinical Cancer Research.

Analysis of genetic variation in Ashkenazi Jews by high density SNP genotyping

Eleazar Eskin, Kenneth Offit, Kirk E Lohmueller, 2008, BMC Genetics.

Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers.

Christos Sotiriou, Edison T Liu, C. Sotiriou, 2002, Journal of the National Cancer Institute.

Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma.

Oscar Lin, J. Boyd, R. Barakat, 2003, Gynecologic oncology.

Gene expression signature with independent prognostic significance in epithelial ovarian cancer.

Marie Joseph, Douglas A Levine, Dimitrios Spentzos, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer.

Laurent Ozbun, Douglas A Levine, J Carl Barrett, 2008, Cancer research.

Gene Expression Profiles Associated with Response to Chemotherapy in Epithelial Ovarian Cancers

Javed Khan, Michael J. Birrer, Christos Sotiriou, 2005, Clinical Cancer Research.

Resistance to therapy caused by intragenic deletion in BRCA2

Jorge S. Reis-Filho, Alan Ashworth, Christopher J. Lord, 2008, Nature.

Implication of snoRNA U50 in human breast cancer.

Wei Zhou, J. Boyd, W. Zhou, 2009, Journal of genetics and genomics = Yi chuan xue bao.

A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer.

Hongzhe Li, Yiling Lu, Joel Greshock, 2014, Cancer cell.

Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studies.

A. Jazaeri, J. Boyd, M. Birrer, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Unique gene expression profile based on pathologic response in epithelial ovarian cancer.

Douglas A Levine, Dimitrios Spentzos, H. Otu, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.